CIK 0001635088 · Large accelerated filer
Roivant Sciences Ltd.
Sign in to watch- Ticker
- ROIV
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Mar 31
- Incorporated
- Bermuda
- Entity type
- operating
- EIN
- 981173944
- Phone
- 441-295-5950
- Business address
- 7TH FLOOR, 50 BROADWAY, LONDON, United Kingdom, SW1H 0DB
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $85,719,562
- in 13 filings, $45.5M under 10b5-1 plans
Net −$85,719,562. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-12 | Torti Frank President and Vant Chair | Other disposition | −329,550 | $40.36 | $13.3M | 12,382,243 |
| 2026-11-12 | Torti Frank President and Vant Chair | Other disposition | −62,493 | $41.13 | $2.6M | 12,319,750 |
| 2026-11-12 | Torti Frank President and Vant Chair | Shares withheld for taxes | −12,800 | $41.85 | $536K | 12,306,950 |
| 2026-11-12 | Gline Matthew CEO | Other disposition | −41,179 | $40.36 | $1.7M | 16,400,638 |
| 2026-11-12 | Gline Matthew CEO | Other disposition | −7,809 | $41.13 | $321K | 16,392,829 |
| 2026-11-12 | Gline Matthew CEO | Shares withheld for taxes | −1,600 | $41.85 | $67K | 16,391,229 |
| 2026-11-12 | Sukhatme Mayukh President & CIO | Other disposition | −44,723 | $40.36 | $1.8M | 18,406,922 |
| 2026-11-12 | Sukhatme Mayukh President & CIO | Other disposition | −8,482 | $41.13 | $349K | 18,398,440 |
| 2026-11-12 | Sukhatme Mayukh President & CIO | Shares withheld for taxes | −1,737 | $41.85 | $73K | 18,396,703 |
| 2026-11-11 | Torti Frank President and Vant Chair | Other disposition | −240,755 | $41.63 | $10.0M | 12,863,086 |
| 2026-11-11 | Torti Frank President and Vant Chair | Other disposition | −151,293 | $42.01 | $6.4M | 12,711,793 |
| 2026-11-11 | Gline Matthew CEO | Other disposition | −30,083 | $41.63 | $1.3M | 16,460,722 |
| 2026-11-11 | Gline Matthew CEO | Other disposition | −18,905 | $42.01 | $794K | 16,441,817 |
| 2026-11-11 | Sukhatme Mayukh President & CIO | Other disposition | −32,672 | $41.63 | $1.4M | 18,472,178 |
| 2026-11-11 | Sukhatme Mayukh President & CIO | Other disposition | −20,533 | $42.01 | $863K | 18,451,645 |
| 2026-11-11 | Pulik Richard CFO | Option exercise | +127,365 | $3.85 | $490K | 397,046 |
| 2026-11-11 | Pulik Richard CFO | Sale | −45,195 | $41.47 | $1.9M | 351,851 |
| 2026-11-11 | Pulik Richard CFO | Sale | −82,170 | $42.03 | $3.5M | 269,681 |
| 2026-11-11 | Pulik Richard CFO | Sale | −47,635 | $41.89 | $2.0M | 222,046 |
| 2026-11-11 | Pulik Richard CFO | Option exercise · Stock Option (Right to Buy) | −127,365 | 487,635 |
Page 1 of 29 · 570 trades